247 related articles for article (PubMed ID: 28703811)
1. Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy.
Wu B; Cui J; Yang XM; Liu ZY; Song F; Li L; Jiang JL; Chen ZN
Cell Death Dis; 2017 Jul; 8(7):e2925. PubMed ID: 28703811
[TBL] [Abstract][Full Text] [Related]
2. Gamma-secretase complex-dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma.
Yong YL; Zhang RY; Liu ZK; Wei D; Shang YK; Wu J; Zhang ZY; Li C; Chen ZN; Bian H
J Pathol; 2019 Oct; 249(2):255-267. PubMed ID: 31215640
[TBL] [Abstract][Full Text] [Related]
3. HAb18G/CD147 inhibits starvation-induced autophagy in human hepatoma cell SMMC7721 with an involvement of Beclin 1 down-regulation.
Gou X; Ru Q; Zhang H; Chen Y; Li L; Yang H; Xing J; Chen Z
Cancer Sci; 2009 May; 100(5):837-43. PubMed ID: 19298604
[TBL] [Abstract][Full Text] [Related]
4. YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle.
Qi S; Su L; Li J; Zhao P; Zhang Q; Niu X; Liu J; Jia G; Wei X; Tavernier J; Jiang J; Chen Z; Zhang S
Cell Death Dis; 2019 Jun; 10(6):462. PubMed ID: 31189879
[TBL] [Abstract][Full Text] [Related]
5. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes.
Qi S; Su L; Li J; Zhang C; Ma Z; Liu G; Zhang Q; Jia G; Piao Y; Zhang S
J Exp Clin Cancer Res; 2019 Nov; 38(1):471. PubMed ID: 31752956
[TBL] [Abstract][Full Text] [Related]
6. Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes.
Wang J; Wu Z; Pan G; Ni J; Xie F; Jiang B; Wei L; Gao J; Zhou W
Nanomedicine; 2018 Aug; 14(6):1949-1961. PubMed ID: 29045824
[TBL] [Abstract][Full Text] [Related]
7. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
[TBL] [Abstract][Full Text] [Related]
8. Basigin-mediated redistribution of CD98 promotes cell spreading and tumorigenicity in hepatocellular carcinoma.
Wu B; Wang Y; Yang XM; Xu BQ; Feng F; Wang B; Liang Q; Li Y; Zhou Y; Jiang JL; Chen ZN
J Exp Clin Cancer Res; 2015 Oct; 34():110. PubMed ID: 26437640
[TBL] [Abstract][Full Text] [Related]
9. CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma.
Tang J; Guo YS; Zhang Y; Yu XL; Li L; Huang W; Li Y; Chen B; Jiang JL; Chen ZN
Cell Death Differ; 2012 Nov; 19(11):1779-90. PubMed ID: 22595757
[TBL] [Abstract][Full Text] [Related]
10. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
11. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
[TBL] [Abstract][Full Text] [Related]
12. N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma.
Li JH; Huang W; Lin P; Wu B; Fu ZG; Shen HM; Jing L; Liu ZY; Zhou Y; Meng Y; Xu BQ; Chen ZN; Jiang JL
Sci Rep; 2016 Nov; 6():35210. PubMed ID: 27869218
[TBL] [Abstract][Full Text] [Related]
13. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN
Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566
[TBL] [Abstract][Full Text] [Related]
14. The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells.
Hu Z; Cai M; Deng L; Zhu L; Gao J; Tan M; Liu J; Lin B
Oncotarget; 2016 Dec; 7(50):82921-82932. PubMed ID: 27863372
[TBL] [Abstract][Full Text] [Related]
15. I
Wu L; Sun B; Lin X; Liu C; Qian H; Chen L; Yang Y; Shen F; Su C
Genes Cells; 2018 Jan; 23(1):35-45. PubMed ID: 29210217
[TBL] [Abstract][Full Text] [Related]
16. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.
Lu M; Wu J; Hao ZW; Shang YK; Xu J; Nan G; Li X; Chen ZN; Bian H
Hepatology; 2018 Jul; 68(1):317-332. PubMed ID: 29356040
[TBL] [Abstract][Full Text] [Related]
17. Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma.
Li X; Zhang Y; Ma W; Fu Q; Liu J; Yin G; Chen P; Dai D; Chen W; Qi L; Yu X; Xu W
Cancer Immunol Immunother; 2020 Apr; 69(4):535-548. PubMed ID: 31965268
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
19. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
Tian H; Huang Y; He J; Zhang M; Ni P
ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation.
Chen R; Wang H; Liang B; Liu G; Tang M; Jia R; Fan X; Jing W; Zhou X; Wang H; Yang Y; Wei H; Li B; Zhao J
Cell Death Dis; 2016 Dec; 7(12):e2512. PubMed ID: 27929538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
